Advertisement

Topics

Seattle Genetics Ends Clinical Trial Of Leukemia Drug After A Higher Rate Of Deaths

11:56 EDT 19 Jun 2017 | eCliniqua

The Seattle Times |  Seattle Genetics said it is discontinuing a Phase 3 clinical trial after data showed "a higher rate of deaths, including fatal infections" in acute myeloid leukemia patients receiving its drug than in the study's other patients.


 
 
 
 

Original Article: Seattle Genetics Ends Clinical Trial Of Leukemia Drug After A Higher Rate Of Deaths

NEXT ARTICLE

More From BioPortfolio on "Seattle Genetics Ends Clinical Trial Of Leukemia Drug After A Higher Rate Of Deaths"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...